
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+13
About Us: Located in the San Francisco Bay Area, Celltheon has been developing Cell Engineering technologies since 2012. Celltheon has patents, granted and pending, for its CHOK-1 derived SUPERCELLTM cell line and its unique DNA and RNA vector elements that are applicable for recombinant biotherapeutics such as Mabs, Difficult to Express Proteins (DEP) as well as for CAR-T, Gene Therapy and Cell Factories applications. Serving the Biotherapeutics Industry with Innovation & Dedication The CELLTHEON SMARTTM Platform has been used to date in 60+ biotherapeutics for oncology, neurobiology and RA programs. In 2018 Celltheon formed strategic partnerships with industry leading companies...
Cell line development,bioproduction,hard to express proteins,qbd,transient expression,stable pools,matching cqas,upstream pd,downstream pd,rcb,cell based assays,3l bio processing,50l scale up,200l scale up,short timelines,qp >50-60pcd,titers >6-7gm/l,and 8-10 weeks to rcb
Celltheon corporation operates in the Biotechnology research industry.
Celltheon corporation's revenue is 11m - 100m
Celltheon corporation has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.